METiS TechBio HK$2.43 billion IPO
We advised METiS TechBio on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
NatWest Markets $20 billion medium-term notes program update
We advised NatWest Markets on its medium-term notes program
Aegon $500 million senior notes offering
We advised the joint book-running managers on the offering
Shanghai Xizhi Technology HK$2.5 billion IPO
We advised Shanghai Xizhi Technology on its IPO and HKEX listing
Mabwell Bioscience HK$1.2 billion IPO
We advised Mabwell on its IPO and HKEX listing
Sumitomo Mitsui Trust Bank $3 billion senior notes offering
We advised SMTB on the update of its global MTN program and senior notes offering
KeyCorp acquisition of Clearwater UK
We are advising KeyCorp on the transaction
Norinchukin Bank $1 billion senior notes offering
We advised the joint lead managers and joint bookrunners on the offering
Adagene $70 million registered direct offering
We advised Adagene on the offering
Nippon Life Insurance $1.85 billion debut senior notes offering
We advised Nippon Life on its debut offering of senior notes